Lehrstuhl für Innere Medizin III

Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracy (2022) Gräf M, Knitza J, Leipe J, Krusche M, Welcker M, Kuhn S, Mucke J, et al. Journal article Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator (2022) Valor-Mendez L, Dorn C, Manger B, Schett G, Kleyer A Journal article, Letter Inflammatory activation of the FcγR and IFNγR pathways co-influences the differentiation and activity of osteoclasts (2022) Grötsch B, Schachtschabel E, Tripal P, Schmid B, Smith AS, Schett G, Bozec A Journal article Persistent inflammation in systemic sclerosis is strongly associated with mortality: a EUSTAR database analysis (2022) Guler SA, Sarbu A, Stadler O, Allanore Y, Bernardino , Distler J, Gabrielli A, et al. Conference contribution Propionate induced bacterial-derived histamine promotes resolution of synovial inflammation (2022) Dürholz K, Lucas S, Schmid E, Schaelter F, Frech M, Azizov V, Hofmann J, et al. Conference contribution The role of joint-draining lymph node stromal cells in inflammatory arthritis (2022) Schälter F, Azizov V, Frech M, Dürholz K, Sokolova M, Hendel A, Focke K, et al. Conference contribution The role of Butyrophilin 2a2 (Btn2a2) in T cell maturation (2022) Frech M, Uchil P, Azizov V, Schober K, Irla M, Sarter K, Zaiss M Conference contribution Microbiota-derived propionate modulates megakaryopoiesis and platelet function (2022) Schmid E, Dürholz K, Frech M, Otterbein N, Lucas S, Rauh M, Schett G, et al. Conference contribution Abatacept Significantly Reduces Subclinical Inflammation During Treatment (6 Months), This Persists After Discontinuation (12 Months), Resulting in a Delay in the Clinical Development of RA in Patients at Risk of RA (The ARIAA Study) (2022) Rech J, Kleyer A, Ostergaard M, Hagen M, Mendez LV, Tascilar K, Krönke G, et al. Conference contribution How Well Does Ultrasound-assessed Synovitis in Reduced Joint Sets Predict the Response to Secukinumab in Patients with Active Psoriatic Arthritis and Inadequate Response to Conventional DMARDs? - Exploratory Results from a Phase 3b Study (2022) D'Agostino MA, Conaghan PG, Gaillez C, Naredo E, Mandl P, Carron P, Senolt L, et al. Conference contribution